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Abstract. Mesenchymal cell migration and neurite
outgrowth are mediated in part by binding of cell sur-
face 01,4-galactosyltransferase (GalTase) to N-linked
oligosaccharides within the E8 domain of laminin. In
this study, we determined whether cell surface GalTase
functions during neural crest cell migration and neural
development in vivo using antibodies raised against
affinity-purified chicken serum GalTase. The antibodies
specifically recognized two embryonic proteins of 77
and 67 kD, both of which express GalTase activity.
The antibodies also immunoprecipitated and inhibited
chick embryo GalTase activity, and inhibited neural
crest cell migration on laminin matrices in vitro. Anti-
GalTase antibodies were microinjected into the head
mesenchyme of stage 7-9 chick embryos or cranial to
Henson's node of stage 6 embryos. Anti-avian GalTase
IgG decreased cranial neural crest cell migration on
T
HE mechanisms by which cells recognize and inter-
act with their environment, either with the extracellu-
lar matrix or with neighboring cells, are initiated at the
cell surface. Several cell surface receptors that function dur-
ing cellular interactions have been identified, characterized,
and subsequently been shown toplay a critical role in embry-
onic development by mediating cellular adhesion or migra-
tion, or by transducing appropriate receptor-mediated sig-
nals that dictate an inductive response (Austin and Kimble,
1987; Takeichi, 1988; Drake and Little, 1991; Flanagan et
al., 1991; Kramer et al ., 1991; Olson et al., 1991) .
One ofthese cell surface receptors is 01,4-galactosyltrans-
ferase (GalTase),' which participates in a number of cellu-
lar interactions, including cell migration and spreading on
laminin matrices (Runyan et al., 1986, 1988; Eckstein and
Shur, 1989; Romagnano and Babiarz, 1990), neurite initia-
tion and outgrowth (Begovac and Shur, 1990; Begovac et al .,
1991), sperm-egg binding (Lopez et al., 1985 ; Miller et al.,
1992), embryonic cell-cell adhesion (Bayna et al., 1988;
Hathaway et al., 1989), and uterine epithelialcell-cell adhe-
sion (Duff et al., 1987). GalTase functions as an adhesion
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the injected side but did not cross the embryonic mid-
line and did not affect neural crest cell migration on
the uninjected side. Anti-avian GalTase Fab crossed
the embryonic midline and perturbed cranial neural
crest cell migration throughout the head. Neural fold
elevation and neural tube closure were also disrupted
by Fab fragments. Cell surface GalTase was localized
to migrating neural crest cells and to the basal surfaces
of neural epithelia by indirect immunofluorescence,
whereas GalTase was undetectable on neural crest cells
prior to migration. These results suggest that, during
early embryogenesis, cell surface GalTase participates
during neural crest cell migration, perhaps by interact-
ing with laminin, a major component of the basal lam-
ina. Cell -surface GalTase also appears to play a role
in neural tube formation, possibly by mediating neural
epithelial adhesion to the underlying basal lamina .
molecule by binding to specific oligosaccharide residues in
the extracellular matrix or on adjacent cells. At present it is
unclear whether cell surface GalTase functions as a lectin,
similar to the selectin class of carbohydrate-binding recep-
tors (Larsen et al., 1990 ; Lowe et al ., 1990), or catalytically,
as occurs in the Golgi during glycoprotein biosynthesis.
Nevertheless, with the increasing body ofevidence implicat-
ing a role for carbohydrates in normal cellular processes
(Kunemund et al., 1988; Reddy et al ., 1989 ; Shur, 1989;
Griffith and Wiley, 1990; Larsen et al ., 1990; Lowe et al.,
1990; Woo et al., 1990; Stamenkovic et al., 1991), it is im-
portant to determine the function of cell surface carbohy-
drate-binding glycoproteins during embryonic development.
The function of cell surface GalTase during cell migration
has been studied extensively in vitro. GalTase is preferen-
tially localized to the leading edges of migrating cells (Eck-
stein and Shur, 1989), where it mediates cell spreading and
migration by binding to N-linked oligosaccharides within the
E8 domain of laminin (Begovac and Shur, 1990). GalTase
does not appear to function during initial cell adhesion to
laminin (Runyan et al., 1988; Romagnano and Babiarz,
1990), nor during cell migration on matrices not containing
laminin (Runyan et al., 1986; Eckstein and Shur, 1989;
Romagnano and Babiarz, 1990). These processes rely upon
other matrix receptors, notably the integrins (Hynes, 1987).
369Laminin induces GalTase expression onto the growing
lamellipodium (Eckstein and Shur, 1989 ; Romagnano and
Babiarz, 1990), where it becomes associated with the
cytoskeleton (Eckstein and Shur, 1992), thus facilitating cell
spreading and migration .
Ultimately, it is critical to determine if molecular models
for cell/matrix interactions developed in vitro actually func-
tion during embryogenesis in vivo . The microinjection of
mRNA into amphibian embryos (Harvey and Melton, 1988 ;
Ruiz i Altaba and Melton, 1989) or of antibodies and com-
peting peptides into amphibian or avian embryos (Boucat et
al ., 1984 ; Bronner-Fraser, 1985 ; Bronner-Fraser and Lal-
lier, 1988) has become a useful method for identifying mole-
cules that play a role in embryogenesis . Antibodies against
specific cell surface receptors, or peptides that compete for
binding to these receptors, block neural crest cell migration
when injected into developing chick embryos . These results
have demonstrated an in vivo role for such cell surface and
extracellular matrix components as integrin (Bronner-
Fraser, 1985), fibronectin (Boucat et al., 1984), the HNK-1
epitope (Bronner-Fraser, 1987), and a laminin/heparin sul-
fate proteoglycan complex (Bronner-Fraser and Lallier,
1988) .
In this study, we examined the role ofcell surface GalTase
during avian embryogenesis . Anti-GalTase IgG and Fab
fragments, which specifically recognized chick embryo Gal-
Tase and inhibited GalTase activity, perturbed avian neural
crest cell migration on laminin matrices in vitro. When these
antibodies were injected into the headmesenchyme of early
chicken embryos, neural crest cell migration was inhibited .
Anti-GalTase Fab fragments also induced neural tube
defects due to their ability to cross the embryonic midline .
GalTase was localized by indirect immunofluorescence to
migrating neural crest cells, as well as to the basolateral
regions of neural epithelial cells . These results suggest a role
for cell surface GalTase in mediating neural crest cell migra-
tion and neurulation in vivo .
Materialsand Methods
Embryos
Fertile White Leghorn chicken eggs were purchased from the Poultry
Department, TexasA&M University (College Station, TX) . Eggs were in-
cubated at 38°C in a humidified chamber for 24-72 h and staged according
to Hamburger and Hamilton (1951) . To collect embryos for in vitro migra-
tion assays and for antibody studies, eggs were broken into sterile 0.9% sa-
line . Embryos were removed from the yolk by cutting through the vitelline
membrane, and theblastoderm was then transferred to PBS . For in vivo as-
says, the eggs were candled to locate the blastoderm and windowed to ex-
pose the embryo. Sterile saline was added to raise the embryo ; India ink,
diluted 1:4, was injected under the blastoderm to aid in visualization of the
embryo. After microinjection, eggs were sealed with electrical tape, rotated
180°, and returned to a 38°C incubation chamber.
Anti-Avian GalTaseAntibodies
Polyclonal anti-chicken serum GalTase antibodies have been previously
characterized (Hathaway et al ., 1991) . Briefly, GalTase was purified from
chicken serum to apparent homogeneity by a-lactalbumin affinity chroma-
tography followed by preparative gel electrophoresis (Hathaway et al .,
1991) . The purified protein was used as immunogen to raise rabbit poly-
clonal antibodies. Antisera with titers of 31/160,000 were used in subse-
quentassays. Purified anti-GalTase IgG immunoprecipitates GalTase activ-
ity from chicken serum and from solubilized chick embryo fibroblasts,
recognizes chicken serum GalTase on Western immunoblots, and inhibits
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chicken serum GalTase activity (Hathaway et al ., 1991) . IgG was prepared
by protein A affinity chromatography (Goding, 1978), and Fab was pre-
pared from purified IgG as described (Hathaway et al ., 1991) .
WesternImmunoblotting
One hundred stage 7-12 chicken embryos were collected as described
above, andthe area opaca and area pellucida were removed . Embryos were
rinsed twice in medium B (NaCI, 7.5 g/liter ; KCI, 0.4 g/liter; Hepes buffer,
4.76 g/liter ; pH 7.2), pelleted, and resuspended in 1 nil of medium B con-
taining a protease inhibitor cocktail (2 Ag/ml antipain, 0.1% aprotinin, 10
Wg/ml benzamidine, 1 pg/ml chymostatin, I pg/ml leupeptin, and 1 pg/ml
pepstatin ; medium B/PIC) . Embryos were solubilized in 1 ml of medium
B/PIC containing 30 mM n-octylglucoside on ice for 2 h. To remove pro-
teins that nonspecifically bound IgG, solubilized embryo proteins were in-
cubated with 100 pg of preimmune IgG overnight at 4°C . The preimmune
IgG-protein complexes were precipitated twice with protein A-Sepharose
(100 Al of a 1 :1 slurry) for 30 min at 4°C .
Solubilized embryo proteins pretreated with preimmune IgG were com-
bined with an equal volume of 2 x polyacrylamide gel sample buffer con-
taining bromophenol blueand 2 mM DTT, then heated to 37°C for 1 h . The
samples were subjected to electrophoresis on 10% SDS-polyacrylamide
gels, and separated proteins were transferred to nitrocellulose overnight at
30 V, 4°C. The nitrocellulose was incubated in 0.1 MTris/0.9% NaCl buffer
containing0 .2% Tween-20 (TTBST 20) and 5% normal goat serum for 2 h
at room temperature followed by overnight incubation at 4°C with primary
antibody (anti-avian GalTaseIgG or preimmune IgG, 10 Ag/ml) in TTBST
20 containing 5% normal goat serum . The nitrocellulose was rinsed for 1 h
with TTBST 20 and incubated 2 h at 4°C in ' 111-goat anti-rabbit IgG
(1 x 105 rpm/ml) in TTBST 20 containing 5 % normal goat serum. The
nitrocellulose was washed six times with TTBST 20, air dried, and exposed
to x-ray film .
To determine whether chick embryo proteins identified by immunoblot-
ting were in fact GalTase, enzyme activity was determined for proteins
eluted from SDS gels. To increase the specific activity of the GalTase ap-
plied to the SDS gel, chick embryo GalTase was partially purified by
a-lactalbumin affinity chromatography . 60 stage 18-20 chick embryos were
solubilized in 4 ml of columnbuffer (0.1 M NaCl, 25 mM sodium cacodyl-
ate, 0.02 % azide)/PIC, containing 1 .0% Triton X-100, on ice for4 h . Insolu-
ble proteins were removed by centrifugation, and the supernatant was ad-
justed to a final concentration of 0.1% Triton X-100 by addition of column
buffer/PIC. GalTase was purified by a-lactalbumin affinity chromatography
as previously described (Hathaway et al., 1991), except that GalTase was
eluted in column buffer without N-acetylglucosamine and containing 1.0 M
NaCl . Peak fractions were pooled, lyophilized, resuspended in 3 ml dH20,
and applied to a desalting column (model IODG ; Bio-Rad Laboratories, Rich-
mond, CA) . Fractions containingproteinwerepooled, lyophilized, resuspended
in 100 Al SDS gel sample buffer containing 2 mM DTT, and then heated
to 37°C for 1 h . 80% of the sample was applied to a single lane of a 10%
SDS gel for elution and renaturation, and the remaining 20% was applied
to two lanes for transfer to nitrocellulose and immunoblotting as described
above . Following electrophoresis, the lane to be renatured was cut into
5-mm pieces ; protein was eluted, precipitated, and renatured ; and GalTase
assays were conducted as described (Hathaway et al ., 1991) .
Immunoprecipitation andInhibition ofGalTase
Activity by Anti-GalTase Antibodies
Stage 18-20 chick embryos were homogenized with a Polytron at a setting
of 10 for 5 s, followed by 40 s at a setting of 6. Insoluble material was
pelleted by centrifugation at 1,000 g for 5 min . Membranes were collected
from the supernatant by centrifugation in an airfuge (Beckman Instr., Inc .,
Fullerton, CA) for 30 min at 200,000 g . For immunoprecipitation assays,
35 gg of total membrane protein was incubated with anti-GalTase IgG or
preimmune IgG overnight at 4°C on a rotator in a total volume of 200 Al
ofmedium B/PIC . Antigen/antibody complexes were precipitated with pro-
tein A-Sepharose (100 Al of a 1:1 slurry ; Pierce, Rockford, IL) . GalTase
activity in the supernatant was assayed as previously described (Hathaway
et al ., 1991), using 100 14M unlabeled UDPgalactose, 1 .0 ACi UDP[3H]-
galactose, 10 mM MnC12 , and 30 mM N-acetylglucosamine . [3H]Galac-
tosylated reaction product was separated from unused UDP[3H]galactose
and its breakdown products by high-voltage borate electrophoresis, and ra-
dioactivity remaining at the origin was quantitated by liquid scintillation
spectroscopy. Background radioactivity was determined by incubating a
sample on ice in parallel, and this value was subtracted from all results .
370For inhibition ofenzyme activity, 100,ug oftotal membrane protein was
incubated with anti-GalTase Fab or preimmune Fab for 1 h on ice with fre-
quentagitation, in a total volume of 125 Al . GalTase assays wereconducted
on aliquots of the membrane-antibody mixtures as described above .
In vitro Migration Assays
Stage 8-10chickembryos were collected as described above . Cranial neural
tubes were isolated and were cultured in laminin-coated (10 pg/ml) 15-mm
wells (Nunc Inc ., Naperville, IL) for 24 h as previously described (Runyan
et al ., 1986) . Neural crest cell migration assays were performed on an in-
verted microscope stage and were examined by time-lapse microphotogra-
phy as previously described (Runyan et al ., 1986) . For each population of
neural crestcells, a basal rateof migration wasestablished . Culture medium
was then replaced with medium containing the antibody reagent, and the
migration rate was determined for the same population of cells . Anti-
GalTàse IgG and preimmune IgG were added at 500 jig/nil, and anti-
GalTase Fab and preimmune Fab at 200 lag/ml . Data obtained from 35-mm
time-lapse films was analyzed as previously described (Runyan et al .,
1986) .
Antibody Microinjection
Stage 6-9embryos were prepared as described above forin vivo microinjec-
tion . To determine the distribution ofmicroinjected IgG and Fab, embryos
were injected with goat anti-rabbit IgG-FITC (1 mg/ml protein; Boehringer
Mannheim Biochemicals, Indianapolis, IN) or goat anti-rabbit Fab-FITC
(10 mg/ml protein; Organon Teknika, Rockville, MD) in PBS, into the em-
bryonic head mesenchyme, lateraltothe mesencephalon . Reagents were ad-
justed for optimal FITC concentration . 5 nl of antibody solution was back-
filled into a glass needle with an internal diameter of 10-20 Am . Needles
were made from 100-g.I micropipets on a vertical micropipet puller (model
720 ; David Kopf Instrs ., Tbjunga, CA) . The solution was injected with a
pulse of air. Embryos were removed to adepression slide either immediately
or after incubating for 1 h at 38°C . Embryos were viewed with epifluores-
cence on a microscope (model Dialux 22 ; E . Leitz, Inc ., Rockleigh, NJ)
equipped with a camera (model FX 35A ; Nikon Inc., Melville, NY) .
To determine the effects ofblocking surface GalTase activity during em-
bryonic development in vivo, antibodies were microinjected into the head
mesenchyme of stage 7-9 chick embryos, lateral to the mesencephalon as
described above. In some experiments, stage 6 embryos were microinjected
just cranial to Hensorfs node . 5 nl ofDME containing anti-GalTase IgG or
Fab (1.3 mg/ml) or preimmune IgG or Fab (1.3 mg/ml) was injected into
the right side ofthe embryo. Eggs were sealed and returned to the incubator
as described above . Embryos were recovered after 4-24 h of incubation,
fixed in Bouin's fixative for 24 h at room temperature, dehydrated through
a graded seriesofethanol, cleared in Hemo-DE (Fisher Scientific, Pittsburgh,
PA), and embedded in Paraplast (Fisher Scientific) . Embryos were serially
sectioned through the transverse plane at 10 Am, mounted ongelatin-coated
slides, and prepared for anti-HNK-1 inununofluorescence to visualize neu-
ral crest cells. Briefly, sections were deparaffrnized with Hemo-DE and re-
hydrated through a graded series of ethanols to PBS . Slides were incubated
for 15 min in PBS with 0.1% BSA . Sections were incubated in anti-HNK-1
(Abo and Balch, 1981) hybridoma culture supernatant overnight at 4°C,
rinsed three times in PBS, incubated in goat anti-mouse IgM (1/50) for 1 h
atroom temperature, rinsedthree times in PBS, andfinally incubated inrab-
bit anti-goat IgG-FITC (1/50) for 1 h at room temperature. Slides were
rinsed and mounted with glycerol/PBS (9 :1) containing4% n-propyl gallate
and were then coverslipped . The sections were viewed with epifluorescence
as described earlier. Following anti-HNK-1 immunofluorescence, the sec-
tions were stained with hematoxylin and eosin . Since cranial neural crest
cells are not anti-HNK-1-immunoreactive in embryosyounger than stage 10,
these sections were stained with hematoxylin and eosin . In all cases, serial
sections wereexamined from the cranial neuropore to the auditory vesicles.
Anti-GalTaseImmunofiuorescence
Stage 5-12 embryos were recovered as described above and fixed for 24 h
at 4°C in St . Marie's fixative (Sainte-Marie, 1962) . Embryos were de-
hydrated through 100% ethanol and embedded in Steedmads low-
temperature embedding medium as described (Norenburg and Barrett,
1987) . Sections were cut at 7Am and floated onto gelatin-coated slides in
dHZ0. The water was removed immediately, and the sections were dried at
room temperature for 48 h . Embedding medium was removed with 100%
ethanol, and the sections were rehydratedinto PBS . Sections were incubated
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overnight at 4°C with anti-GalTase antisera or preimmune sera (1150),
diluted in PBS containing 5% normal goat serum . Slides were rinsed three
times in PBS, then incubated in goat anti-rabbit IgG-FITC (1150) for 1 h
at room temperature. Slides were rinsed, coverslipped, and viewed as de-
scribed above.
Alternatively, to visualize predominantly cell surface-associated Gal-
Tase, embryos were treated with antibodies before embedding using a tech-
nique modified from Martins-Green and Tokuyasu (1988) . Embryos were
cut transversely into several pieces with a scalpel, then fixed for 30 rein at
room temperature in Bouin's fixative. After rinsing 1 h in 70% ethanol and
1 h in 0.2M phosphate buffer containing 0.02 % NaN3 and 0.002% Triton
X-100 (the latter to serve as a surfactant) (PNT), aldehyde groups were
blocked by incubation in PNT containing 0.1 M glycine for 30 min at room
temperature . Embryos were incubated overnight at 4°C with anti-GalTase
antisera or preimmune sera (1/50) in PNT containing 5% normal goat se-
rum, washed for 6 h with PNT, incubated overnight at 4°C with goat
anti-rabbit IgG-FITC (1/50) in PNT with 5 % normal goat serum, and
washed for 6 h in PNT. Finally, embryos were fixed again for 1 h, blocked
with 0.1 M glycine, dehydrated through 100% ethanol, cleared in Hemo-
DE, and embedded in Paraplast .
Results
Identification ofChick Embryo Membrane GalTase
by Western Immunoblotting
The anti-GalTase antibody used in this study has been shown
previously to react with avian GalTase from chicken serum
and from chick embryo fibroblasts (Hathaway et al., 1991) .
The specificity of the antibody toward chick embryo GalTase
was determined using solubilized whole stage 7-12 embryos
(for Western immunoblotting) ormembranes prepared from
stage 7-12 embryos (for immunoprecipitation and inhibition
assays) . The anti-avian GalTase antibody recognized two
proteins with apparent molecular masses of 77 and 67kD on
Western immunoblots (Fig. 1) . Both the anti-GalTase and
preimmune antibodies nonspecifically labeled several addi-
tional proteins, but these were eliminated by pretreating
the solubilized embryos with preimmune IgG and protein
A-Sepharose before gel electrophoresis (not shown) . After
preimmune IgG pretreatment, two nonspecifically labeled
bands were still detected, at 55 kD (asterisk, Fig. 1) and at
>85 kD (double asterisk, Fig . 1) . The higher molecular
weight band, which occurred as a result of preimmune IgG
pretreatment, does not mask any proteins labeled specifically
by anti-GalTase IgG, as assessed by immunoblots in which
pretreatment with preimmune IgG was omitted (not shown) .
To determine if these polypeptides are in fact GalTase,
GalTase was identified in stage 18-20 embryos by elution
and renaturation of a-lactalbumin-purified glycoproteins
resolved by SDS-PAGE . GalTase activity was primarily as-
sociated with the 77- and 67-kD polypeptides that reacted
specifically with the anti-GalTase IgG by Western blotting.
Significant GalTase activity was not detectable in any other
portion of the gel, including the two nonspecifically labeled
bands . No protein bands were detectable on silver-stained
gels between the 77- and 67-kD proteins, thus ruling out the
possibility that another protein(s) not immunolabeled with
anti-GalTase antibody was responsible for the GalTase activ-
ity (not shown) . Similar results were obtained in three sepa-
rate assays . The 77- and 67-kD proteins consistently showed
high levels of activity, although they were not always equal
to one another, supporting the notion that the two polypep-
tides are related by proteolysis, as is commonly found with
mammalian GalTases (Smith and Brew, 1977) . It is likely
37 1Figure 1. Identification ofchick
embryo GalTase by Western
immunoblotting . Solubilized
stage 7-12 chickembryos were
pretreated with preimmune
IgG and protein A-Sepharose,
electrophoresed on 10% SDS
polyacrylamide gels under re-
ducing conditions, and trans-
ferred to nitrocellulose . Pro-
teins were immunolabeled with
polyclonal anti-avian GalTase
IgG (lane 1) or preimmune
IgG (lane 2), as described in
Materials and Methods . Two
proteins with apparent molec-
ular masses of 77 and 67 kD
were specifically labeled by
the anti-GalTase antibody . As
a result of preimmune IgG/
protein A-Sepharose pretreat-
ment, a nonspecific, high mo-
lecular weight protein was
seen in both anti-GalTase-la-
beled and preimmune-labeled
lanes (**) . In addition, a band
with apparent molecular mass
of 55 kD nonspecifically la-
bels with both anti-GalTase
and preimmune IgG (*) . Mo-
lecular mass was determined
by linear regression analysis,
and positions of molecular
weight markers are indicated to the right : (o), origin ; (df) dye
front . To determine GalTase activity, protein was eluted from the
gel and renatured, and GalTase assays were performed as described
in Materials and Methods . Totalcpm is indicated to the left of the
gel, for each sample measured . Background radioactivity averaged
918 cpm and was subtracted from each sample.
that the 77-kD GalTase protein is the same protein as that
affinity-purified from chick embryo liver (Furukawa and
Roth, 1985), as judged by their migration relative to BSA
standards .
Immunoprecipitation and Immunoinhibition of
ChickEmbryo GalTase Activity
The anti-avian GalTase antibodies have been shown previ-
ously to immunoprecipitate GalTase activity from chicken
serum and from chick embryo fibroblasts (Hathaway et al .,
1991) . In this study, the anti-GalTase IgG was shown to im-
munoprecipitate chick embryo membrane GalTase activity
as well, and in a dose-dependent manner (Fig . 2A) . No en-
zyme activity was precipitated using preimmune IgG .
The anti-GalTase antibodies were also shown previously
to inhibit GalTase activity toward both high molecular
weight and monosaccharide substrates (Hathaway et al .,
1991) . As shown here, anti-GalTase Fabpreparations also in-
hibited GalTase activity in chick embryo membranes and did
so in a dose-dependent manner (Fig . 2B) .
Neural Crest Cell Migrationon Laminin
Matrices In Vitro
Avian cranial neural crest cells have been shown to migrate
The Journal of Cell Biology, Volume 117, 1992
Figure 2 . Immunoprecipitation and inhibition ofchick embryo Gal-
Tase activity by anti-GalTase antibodies. (A) GalTase activity from
stage 18-20 chick embryo membranes was precipitated with anti-
GalTase IgG or preimmune IgG as described in Materials and
Methods, and GalTase activity remaining in the supernatant was de-
termined . 22% of the enzyme activity remained in the supernatant
with 5 /,g/ml anti-GalTase IgG, and 11% with 50 pg/ml IgG . No
additional precipitation was observed with greater concentrations
ofantibody. Preimmune IgGhad no effect on GalTase activity, com-
pared to controls containing no antibody. background radioactivity
averaged 119cpm and was subtracted from each sample . (B)Mem-
brane proteins prepared from stage 18-20 chick embryos were in-
cubated in the presence of anti-GalTase Fabor preimmune Fab, and
enzyme activity was determined as described in Materials and
Methods . At 200 14g/ml Fab, GalTase activity was inhibited by 42
and 45%, compared to preimmune controls, and at 400 ug/ml,
inhibition increased to 57 and 70% . The data are expressed as a
percent of preimmune control . Actual cpm products forpreimmune
controls were 15,065 at 200 pg/ml and 18,339 at 400 pg/ml . Back-
ground radioactivity averaged 250 cpm and was subtracted from all
samples .
on laminin in a GalTase-dependent manner (Runyan et al .,
1986) ; therefore, this in vitro assay system was used to deter-
mine whether anti-GalTase antibodies can inhibit neural
crest cell migration . Cranial neural crest cells were isolated
and allowed to migrate onto laminin substrates in vitro as de-
scribed in Materials and Methods . The rate of migration for
a population of neural crest cells was determined in the pres-
ence and absence of anti-GalTase antibodies . Anti-GalTase
Fab inhibited the rate ofmigration by 66%, from 54.4 to 23 .7
p,m/h (Fig . 3) . Preimmune Fab had no significant effect on
migration rate. Anti-GalTase IgG also inhibited migration
(data not shown) . Basal rates of migration in all assays were
similar (52.1 f 3.5 p,m/h), and basal rates for the ex-











m a . - e-
H -
V 1000 - C7
0 s 50 zooFigure 3 Anti-GalTase Fab
inhibits neural crest cell mi-
gration on laminin in vitro.
Neural crest cells were cul-
tured on laminin matrices as
described in Materials and
Methods, and their migration
rates were determinedbefore and after addition ofanti-GalTase Fab
(Anti-GT Fab) or preimmune Fab (PI Fab) . Migration rate in the
presence of preimmune Fab did not change significantly (54 .8 vs.
54.4,um/h) ; however, migration rate decreased by 66%, from 54.4
to 23 .7 um/h, in the presence of anti-GalTase Fab . Bars indicate
standard errors.
varied by<3.0 /Am/h . The anti-GalTase and preimmune anti-
bodies were shown to be nontoxic, since neural crest cells
suffered no loss in viability after 24 h of culture in these re-
agents .
In summary, these results confirm earlier work that estab-
lished a role for cell surface GalTase in avian neural crest cell
migration on laminin matrices (Runyan et al ., 1986) . The ex-
periments shown here also demonstrate that antibodies that
inhibit chicken serum GalTase activity specifically recognize
and inhibit chick embryomembrane GalTase activity, as well
as inhibit surface GalTase activity in biological assays . The
effects of anti-GalTase antibodies on chick embryo GalTase
are both specific and dose-dependent, and are therefore ap-
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propriate reagents for testing the consequences ofperturbing
cell surface GalTase activity during development in vivo.
Distribution ofIgG andFabMicroinjected
into Chick Embryos
We initially determined the distribution of both IgG and Fab
reagents injected into the chick embryo head mesenchyme .
Fluoresceinated IgG or Fab was microinjected into the right
side ofstage 8-9 chick embryonic head mesenchyme, lateral
to the mesencephalon . After 1 h, whole embryos were exam-
ined by fluorescence microscopy to visualize the antibody
distribution . IgG was evenly distributed throughout the in-
jected side of the head, but no label was detected on the un-
injected side (Fig. 4 a), in agreement with studies by oth-
ers demonstrating a unilateral distribution of microinjected
IgG (Bronner-Fraser, 1985) . The uninjected side therefore
served as a positive control . In contrast, Fab injected into the
right head mesenchyme became localized to both sides ofthe
head after 1 h (Fig. 4 b), demonstrating that Fab fragments
crossed the embryonic midline . Some embryos were exam-
ined immediately after microinjection to ensure that the
bilateral distribution of the Fab was not due to microinjec-
tion error (not shown) .
Anti-GalTase IgG Inhibits Neural Crest Cell
Migration Unilaterally
Cranial neural crest cells initiate migration from the dorsal
Figure 4 . Distribution ofIgG and Fab microinjected into chick embryos. Fluorescein-conjugated IgG or Fab was microinjected into stage
8-9 chick embryonic heads, in the right side of the mesenchyme lateral to the mesencephalon . After I h, the distribution of antibody
was determined by fluorescence microscopy of whole embryos . IgG did not cross the midline to the left side (a), whereas Fab could be
found throughout the head mesenchyme after 1 h (b) . (Insets) Phase contrast views of the respective embryos. Bar, 50 gym .Table I. Anti-GalTase Antibodies Inhibit
Neural Development
For IgG-treated embryos, abnormal refers to neural crest cells on the inject-
ed side compared with the uninjected side.
*39% of abnormal embryos had defective neural crest cell migration, 61%
had neural tube defects, and 4% showed an overall inhibition of normal de-
velopment .
aspect of the closing neural tube, moving laterally and ven-
trally beneath the skin ectoderm . Anti-GalTase IgG was
microinjected into the pathway of migrating cranial neural
crest cells on one side of the chick embryonic head mesen-
chyme . Control embryos were injected with preimmune IgG
ormedium alone . Embryos were incubated for an additional
4-8 h, harvested, and the neural crest cells visualized by
anti-HNK-1 immunofluorescence on sections. The results
from these experiments are presented in Table I . Whereas
only 1 of 31 (3%) control-injected embryos showed any de-
fect in neural crest cell migration, 10 of 15 (67%) embryos
microinjected with anti-GalTàse IgG showed abnormal
cranial neural crest cell migration on the injected side of the
embryo, compared with the uninjected side. Examples of
IgG-injected embryos are shown in Fig. 5 and 6. In Fig . 5,
a and b, an anti-GalTase IgG-injected embryo is shown at the
level ofthe mesencephalon (midbrain) and the myelencepha-
Ion (hindbrain), respectively. The neural crest cells on the
injected side (to the left in the micrograph) in this stage 11
embryo showed retarded ventrolateral migration . In addi-
tion, the neural crest cells have migrated inan anomalous po-
sition at the level ofthe hindbrain (Fig. 5 b), where they were
in close contact with the neural tube on the injected side. A
higher magnification view of a stage 10+ embryo comparing
neural crest cell migration patterns on the anti-GalTase IgG-
injected and uninjected sides ofthesame section is presented
in Fig. 6. The neural crest cells on the injected side have not
migrated as far ventrally as on the control side (Fig. 6, ar-
rows) . These observations are consistent throughout the mid-
brain and hindbrain regions of affected embryos, as assessed
by examination of serial sections . No other developmental
abnormalities were detected in embryos treated with anti-
GalTase IgG.
Anti-GalTase Fab InhibitsNeural Crest Cell
Migration Bilaterally
Anti-GalTase Fab was microinjected into the right head
mesenchyme of stage 7-9 chick embryos. Stage 6 embryos
were microinjected just cranial to Henson's node . Embryos
were incubated for an additional 4-24 h, developing to
Figure 5 . Anti-GalTase IgG inhibits neural crest cell migration uni-
laterally. Embryos were microinjected with IgG into the right head
mesenchyme, lateral to the mesencephalon (the left side in the mi-
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crographs), and prepared for anti-HNK1 immunofluorescence to
visualize neural crest cells. (a and b) Cross-sections through the
mesencephalon (a) and the myelencephalon (b) of the same stage
11 (13 somite) embryo treated with and-GaIMase IgG. The level of
ventrolateral migration attained by the neural crest on the injected
side was less than that on the uninjected side (arrows) . Further-
more, neural crest cells migrated in an anomalous position in the
hindbrain, where they were in close contact with the neural tube,
compared with the neural crest on the uninjected side . (c) Embryos
injected with preimmune IgG showed mormal neural crest cell mi-
gration compared with the uninjected control side, as shown in a
stage 11 embryo (arrows) . Both embryos were incubated for 12 h









Medium only 15 15(100%) 0
Preimmune IgG 16 15(94%) 1(6%)
Anti-GalTase IgG 15 5(33%) 10(67%)
Preimmune Fab 51 49(96%) 2(4%)
Anti-GalTase Fab 64 36(56%) 28(44%)$Figure 6 . Anti-GâlTase IgG inhibits neural crest cell migration unilaterally . Higher magnification view of a stage 10+ (11 somite) embryo
treated with and-GalTase IgG, demonstrating unequal ventrolateral migration of the cranial neural crest cells on the injected side (a)com-
pared with the uninjected side (b) ofthesame embryo . aandb arefrom the same section . Neural crest cells werevisualized by anti-HNK-1
immunofluorescence . The position of neural crest cellsshown in this panel is reflected throughout the mesencephalon and myelencephalon
of this embryo, as judged by examination of serial sections . The embryo was incubated for 4 h following microinjection . Bar, 25 pm.
stages 8-15, harvested, andprepared foranti-HNK-1 immu-
nofluorescence. The neural crest cells of embryos younger
than stage 10 do notexpressanti-HNK-1 immunoreactivity ;
therefore, these embryoswere stained with hematoxylin and
eosin only.
Results from Fab microinjections of 115 embryos are
presented in Thble I. Only 2 of 51 (4 %) preimmune-injected
embryos demonstrated abnormalities in cranial neural crest
cell migration . However, 28 of 64 (44%) embryos injected
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with anti-GalTàse Fab demonstrated defects in neural crest
cell migrationor neural tube formation . 39% ofaffectedem-
bryos showed defects in neural crest cell migration.A wider
rangeofembryonicages wasexamined in Fabmicroinjection
assays, andconsequently, feweroftheseembryos hadneural
crest defects compared with embryos injected with IgG .
Some Fab-injected embryos were harvested before signifi-
cant neural crest cell migration hadbegun, and many were
allowedto develop 20-24 hafter injection, perhaps allowing
375
Figure 7 . Anti-GalTàse Fab inhibits
neural crest cell migration bilaterally.
Embryos microinjected with anti-Gal-
Tase Fab to the right side of the mesen-
chyme lateral to the mesencephalon
demonstrate bilaterally decreased neu-
ral crest cell migration (a and c), com-
pared with age-matched embryos mi-
croinjectedwithpreimmuneFab (band
d) . a and b are stage 10- (9 somites)
and c and d are stage 10+ (11 somite)
embryos. Neural crest cells were visu-
alized by anti-HNK-1 immunofluores-
cence. All embryos were incubated for
7 h after microinjection . Bar, 50 ,m.Figure 8. Neural crest cell migration defects associated with anti-GalTàse Fab . (a and d) The same stage 12 anti-GalTàse Fab-treated
embryo at different magnifications. Neural crest cells remained associated with the dorsal neural tube (arrows) and entered the neural tube
(arrowheads) . (b) A preimmune Fab-treated embryo at the same stage . These embryos were incubated for 20 h following microinjection .
The section shown in a was cut at an oblique angle showing the auditory vesicle (av) . (e) The embryo was incubated for 12 h following
microinjection, developing to stage 13- (18 somites) . Neural crest cells remained associated with the dorsal neural tube (arrows) . (c) An
age-matched preimmune Fab-treated embryo. Neural crest cells all migrated ventrolaterally away from the neural tube. Neural crest cells
were visualized by anti-HNK-1 immunofluorescence . Bars : 50 pm (a-c) ; 25 tm (d and e) .
sufficient dilution ofthe Fab and recovery of neural crest cell
migration . Except for the observed perturbation of neural
crest cell migration and neural tube defects discussed below,
longerterm development (i.e ., 20-24h after injection) ofanti-
GalTase Fab-treated embryos appeared normal and com-
parable to age-matched controls in all but two embryos (4%) .
Fig . 7 depicts stage 10- (Fig . 7, a and b) or stage 10+
(Fig . 7, c and d) embryos microinjected with anti-GalTase
Fab (Fig. 7, a and c) or preimmune Fab (Fig. 7, b and d) arid
incubated for 7 h following injection . The cranial neural
crest cells of the anti-GalTase-treated embryos did not mi-
grate as farventrolaterally as the neural crest cells inthe con-
trol embryos . The reduced size of the anti-GalTase Fab-
treated heads may be due to the reduced migration of the
neural crest .
Neural crest cells in anti-GalThse Fab-treated embryos
were frequently found associated with the dorsal neural tube,
long after these cells have migrated away from this area in
normal embryos (Fig . 8) . The cranial neural crest cells in
anti-GalTase Fab-injected embryos (Fig . 8, a, d, and e) did
not completely migrate away from the dorsal neural tube,
andsome cells entered the neural tube. Neural crest cell dis-
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tribution was normal in preimmune Fab-injected embryos
(Fig . 8, b and c) .
Collectively, these results suggest that perturbation of cell
surface GalTase activity inhibits the initial stages of neural
crest cell migration . Once migration has commenced, i.e .,
at stage 10 or later, cranial neural crest cells were not
affected by perturbation ofcell surface GalTase (not shown) .
These results support a function for cell surface Gallhse dur-
ing initial emigration of cranial neural crest cells away from
the dorsal neural tube.
Anti-GalTase Fab Disrupts Neural Tube Formation
In addition to inhibiting migration of cranial neural crest
cells, injection of anti-GalTàse Fab into the head mesen-
chyme resulted in neural tube defects in 61% of treated em-
bryos . Neural tubes developed normally in 100% ofcontrol
embryos . The defects are best summarized as an abnormal
neural fold elevation and lateral hinge plate formation
(Schoenwolf and Smith, 1990), and incomplete neural tube
closure . Anti-GalTàse Fab-injected, hematoxylin and eo-
sin-stained embryos are shown in Fig . 9, a, b, and d, at stage
376Figure 9 . Anti-GalTase Fab
disrupts normal neural tube
formation. (a-c) Embryos were
microinjected with Fab atstage
6, just cranial to Henson's
node, and harvested after 4 h,
at stage 8+ (five somites) . An-
ti-GalTase Fab caused incom-
plete neural tube closure (a
and b), whereas preimmune
Fab-treated embryos were
normal (c) . In a, median hinge
formation has occurred nor-
mally (arrowhead), but neu-
ral folds have not elevated . In
b, neural fold elevation has
proceeded normally (open ar-
rowheads), but lateral hinge
formation has failed . Normal
lateral hinge formation is seen
in control embryos (c, ar-
rows) . (d and e) The embryos
were microinjected at stage 8
and incubated for an additional 6 h to stage 10- (9 somites) . Lateral hinge formation was abnormal in the anti-GalTàse Fab-treated em-
bryo (d), as compared with embryos treated with preimmune Fab (e, arrows) . Development otherwise appeared normal . Sections were
stained with hematoxylin and eosin . Bar, 50 gym .
8+ (Fig . 9, a and b) or stage 10- (Fig . 9 d) . Age-matched
preimmune Fab-injected controls are also shown (Fig . 9, c
and e) . Neural tube closure was incomplete in anti-GalTase
Fab-treated embryos due to a failure ofneural fold elevation
(Fig . 9 a) or lateral hinge formation (Fig . 9,band d) . A stage
13+ embryo, incubated for 20 h after microinjection with
anti-GalTàse Fab (Fig . 10, a, c, and d), had an open neural
tube in the forebrain region, and HNK-1-positive neural
crest cell material had entered the hindbrain (Fig. 10 c) . De-
velopment otherwise appeared normal in this embryo, indi-
cating that anti-GalTase perturbation of neural tube closure
persists in the absence of any obvious secondary defects . Fi-
nally, some anti-GalTase Fab-injected embryos showed bi-
furcated neural tubes resulting from inward folding of the
dorsal neural tube (Fig. 11) .
In summary, treatment of embryos with anti-GalTase anti-
bodies affects neural crest cell migration unilaterally (IgG)
or bilaterally (Fab) compared to embryos microinjected with
preimmune antibodies . These effects correlate well with the
distribution of microinjected IgG and Fab reagents . Serial
sections were examined for all embryos, and affected em-
bryos showed neural crest cell defects in large regions ofthe
mid- and hindbrain areas. Most of the defects consisted of
reduced or anomalous migration of neural crest cells, al-
though some embryos appeared to have a reduced volume of
neural crest cells . The volume ofHNK-1 positively stained
cells was determined for two representative IgG-injected
embryos, and was found to be reduced by 29 and 14% on
the injected side . Because of these small differences, and be-
cause quantitation of HNK-1-immunoreactive regions is
imprecise owing to the loose association ofneural crest cells,
determination ofneural crest cell volume was not continued .
Finally, anti-GalTase Fab affected neural tube development,
resulting in abnormal neural fold elevation and incomplete
or improper neural tube closure .
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IndirectImmunofuorescence Localization ofGalTase
The distribution of GalTase was determined by indirect im-
munofluorescence on serially sectioned embryos that had
been embedded in low-temperature embedding medium .
GalTase was localized to most cell types, as expected, since
GalTase is a component ofthe Golgi apparatus (Fig. 12) . Be-
fore the onset of migration, presumptive cranial neural crest
cells did not express significant levels of anti-GalTase im-
munoreactivity (Fig . 12 a) ; however, label was associated
with these cells as they began to migrate away from the dor-
sal neural tube (Fig . 12 c) . GalTase immunoreactivity was
heavieston the leading cells of the migratory neural crest cell
cluster (Fig . 12 c), and they continued to express GalTase
at later stages of migration (Fig. 12 d) . The migratory head
mesenchyme also expressed Ga]Tase (Fig . 12, a, c, and d) .
Comparison to anti-HNK-1 labeling, an epitope localized
exclusively to the cell surface (Vincent and TTtiery, 1984),
in double-label experiments suggests that a high proportion
of the GalTase on these migratory cell types is associated
with the cell surface (not shown) . In addition, GalTase was
localized to the interface between the neural epithelia andthe
ectoderm (Fig . 12 g), to the basal surfaces and regions of
neural epithelial cells (Fig . 12 h), as well as to the basal sur-
face of the notochord, gut endoderm, and vascular en-
dothelium in older embryos (Fig . 12 h) . Finally, anti-
GalThse immunofluorescence was detectable on the apical
surfaces and regions of ectodermal cells (Fig . 12, c, d, and
g), which may represent a secretory form of GalTase often
associated with secretory epithelia (Both et al ., 1985) .
A preembedding immunofluorescence technique was used
to enhance the visualization ofGalTase associated with basal
lamina (Martins-Green and Tokuyasu, 1988) . Anti-GalTase
antibody heavily labeled the basal surfaces of neural epithe-
lial cells ofearly neurula-stage embryos (stages 7-8 ; Fig . 12
377Figure 10. Anti-GalTase Fab disrupts neural tube formation . The
stage 13+ (20 somite) embryo whole mount shown in a was micro-
injected with anti-GalTàse Fab at stage 8 and incubated for an
additional 20 h . The neural tube in the forebrain region (arrow) re-
mained open . A control stage 13- (18 somite) embryo microin-
jected with preimmune Fab, shown in b, appeared normal. The
embryo in a was serially sectioned and prepared foranti-HNK-1 im-
munofluorescence (c) and for hematoxylin and eosin staining (d) .
The open neural tube ofthe forebrain is evident (arrows), and some
HNK-1-positive neural crest cell material has entered the neural
tube in the hindbrain region (c, arrowhead) . Neural crestcellmigra-
tion and development otherwise appeared normal in this embryo.
Bars : 500,um (a and b) ; 50 pm (c and d) .
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e) . Control sections treated with preimmune sera demon-
strated no detectable fluorescence associated with the basal
neural epithelia (Fig. 12, b andf) .
Discussion
Our interest in cell surface GalThse function during em-
bryonic development is based upon previous work demon-
strating that GalTase is present at high levels on the surface
of migrating cells and between cells and tissues undergoing
inductive interactions (Shur, 1977) . These results suggested
that cell surface GalTase might participate during these
events . Subsequent in vitro studies showed that GalTase par-
ticipates during neural crest cell migration on laminin ma-
trices (Runyan et al ., 1986) . However, it is necessary to
determine whether molecular models for cell-matrix inter-
actions developed in vitro are actually functional during
development in vivo . Consequently, in this study we exam-
ined the role of cell surface GalTase during neural crest cell
migration and neural development in vivo . The antibody
used in these experiments was raised in rabbits against
chicken serum GalTase purified to apparent homogeneity
(Hathaway et al ., 1991) . The polyclonal antibody recognized
avian GalTase as determined by several criteria, including
ELISA, immunoprecipitation of enzyme activity from se-
rum and chick embryo fibroblasts, inhibition ofenzyme ac-
tivity, and by Western immunoblotting (Hathaway et al .,
1991) . In this study, the antibody specifically recognized
chick embryo GalTase as shown by Western blotting poly-
peptides that contained GalTase enzymatic activity following
renaturation . The antibodies also inhibited chick embryo
membrane GalTase activity in a dose-dependent manner,
suggesting that the polyclonal antibodies recognize epitopes
at or near the active site.
The efficacy of these antibodies for in vivo studies was es-
tablished using an appropriate in vitro assay. Cranial neural
crest cells migrate on laminin in a GalTase-dependent man-
ner, since migration is inhibited by the GalTase modifier pro-
tein a-lactalbumin and by competitive substrates, and is en-
hanced by the sugar nucleotide substrate, UDPgalactose
(Runyan et al ., 1986) . Anti-GalThse IgG and Fab both
significantly inhibited the migration of these cells in vitro,
without affecting viability. These antibodies are therefore
specific, inhibitory, nontoxic, and react with GalThse in a
dose-dependent, saturable manner.
The distribution of IgG and Fab reagents was established
by microinjection into the head mesenchyme of stage 8-9
chick embryos . IgG did not cross the embryonic midline af-
ter 1 h of incubation, in agreement with published findings
(Bronner-Fraser, 1985) . On the other hand, Fab crossed the
midline within 1 h of incubation . The inability of IgG to
cross the midline may simply reflect its larger size relative
to Fab fragments, which quickly diffuse throughout the
head . Alternatively, putative Fc-binding sites on embryonic
cells may prevent IgG from diffusing far from the site of in-
jection .
Anti-GalTase IgG was microinjected into the chick em-
bryonic head mesenchyme, lateral to the mesencephalon of
stage 7-9 embryos . Neural crest cell migration was affected
only on the injected side of the embryo . Neural crest cell
migration was also perturbed with anti-GalTase Fab, but
both sides ofthe embryo were affected. Insome cases, neural
378crest cells were observed in anomalous positions, such as
within the neural tube, dorsal to the neural tube after ven-
trolateral migration would normally have been completed,
or in contact with the lateral neural tube rather than in con-
tact with the ectoderm .
GalTase immunoreactivity was low on neural crest cells
before the onset of migration, but appeared on the leading
cells in the neural crestpopulation as they initiated migration
away from the dorsal neural tube . A comparison of the pat-
tern of anti-GalTase and anti-HNK-1 immunoreactivities on
the same sections suggests that a significant portion of the
GalTase resides on the cell surface . This conclusion is sup-
ported by the fact that migratory neural crest cells express
cell surface GalTase activity (Runyan et al ., 1986), although
the relative amount of cell surface and intracellular GalTase
in neural crest cells has not been determined. Collectively,
these data suggest that cell surface GalTase may function
during the initial migration of neural crest cells away from
the neural tube . During this time, neural crest cells are in
closest contact with a laminin-rich basal lamina that lines the
basolateral surface of both the ectoderm and the neural tube
(Duband and Thiery, 1987 ; Martins-Green and Erickson,
1987) . Since GalTase mediates cell-laminin interactions in
vitro, our data are consistent with the hypothesis that surface
GalTase on migratory cranial neural crest cells mediates, in
part, their interaction with laminin within the basal lamina
of adjacent epithelia and within the extracellular matrix, thus
influencing migration . This is further supported by the fact
that the E8 domain of laminin supports neural crest cell
migration (Perris et al ., 1989), and has been identified as the
surface GalTase-binding site within laminin (Begovac et al.,
1991) . In vitro studies have shown that laminin induces sur-
face GalTase expression on migrating mesenchymal cells
(Eckstein and Shur, 1989), raising the possibility that the
basal laminamay induce surface GalTase expression on adja-
cent neural crest cells, thus initiating migration .
An in vivo study is usually not well suited to quantitation,
however the overall extent and type of neural crest cell defect
seen in this study appears to reflect a decrease in the rate of
migration of this cell type . The most commonly seen defect
was reduced ventrolateral migration of neural crest cells on
the injected side of the embryo (IgG studies) or compared
to age-matched preimmune controls (Fab studies) . This
reduction was never absolute ; some migration ofneural crest
cells was always observed in affected embryos . Although we
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Figure 11. Anti-GalTase Fab
induces abnormal neural tube
closure . (a) In some anti-Gal-
ZhseFab-treated embryos, neu-
ral tube closure resulted in
a dorsally bifurcated neural
tube, possibly resulting from
an overrotation of the dorsal
neural folds (arrow), as shown
in this stage 11+ (14 somite)
embryo incubated for 20 h fol-
lowing antibody treatment . (b)
Anage-matched control-treated
embryo, with normal neural
tube closure . Sections were
stained with hematoxylin and
eosin . Bar, 50 pm .
cannot rule out the possibility that the anti-GalTase reagent
becomes diluted so as to allow some recovery of migration
by the earliest observation time (4 h), these results suggest
that cell surface GalTase is one of several cell surface recep-
tors involved in mediating neural crest cell migration in vivo .
In light of the work of others (Boucat et al., 1984 ; Bilozur
and Hay, 1988 ; Bronner-Fraser, 1985, 1987 ; Bronner-Fraser
and Lallier, 1988) demonstrating roles for other cell surface
receptors and extracellular matrix components in neural
crest cell migration, a cooperative, partially overlapping se-
ries of cell-matrix events is most probable .
This notion is further supported by the fact that the migra-
tory defects produced by anti-GalTase antibodies showed
subtle, but characteristic, differences from those produced
by antibodies against other cell surface receptors and matrix
components . Antibodies against integrin (Bronner-Fraser,
1986), the HNK-1 epitope (Bronner-Fraser, 1987), or the
laminin-heparin sulfate proteoglycan complex (Bronner-
Fraser and Lallier, 1988) all produced ectopic neural crest
cells ; a defect rarely seen after anti-GalTase antibody treat-
ment . Since surface GalTase participates exclusively during
cell spreading and migration, and not during initial cell at-
tachment to laminin which involves other matrix receptors
(Runyan et al., 1988), it is possible that defects following anti-
GalTase treatment directly reflect defects in migration, and
not secondary defects in cell-cell or cell-matrix adhesions .
A few embryos treated with anti-GalTase antibodies had
a small reduction in neural crest cell volume associated with
decreased migration . Others have reported similar findings
using antibodies against different cell surface receptors to in-
hibit cranial neural crest cell migration (Bronner-Fraser,
1986, 1987) . Reduced neural crest cell volume is not a pri-
mary defect of anti-GalTase antibody treatment, since not all
embryos showing defective migration showed concomitant
decreases in neural crest volume. It is not clear in either the
present study or in others, ifthe reduced neural crest cell vol-
ume is due to fewer cells or due to neural crest cells cluster-
ing together as a result of antibody perturbation . Any effects
on neural crest volume or cell number were not due to anti-
GalTase antibody toxicity, since these reagents had no effect
on the viability of cultured neural crest cells (the present
study) or cultured chick embryo fibroblasts (unpublished ob-
servations), nor did these reagents affect neural crest volume,
cell number or migration after stage 10 of development, al-
though these cells are still dividing (Maxwell, 1976) .
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380The inability of anti-GalTase antibodies to affect neural
crest migration during later stages of development (after
stage 10) is similar to that reported by others using antibod-
ies against the HNK-1 epitope (Bronner-Fraser, 1987) and a
laminin-heparin sulfate proteoglycan complex (Bronner-
Fraser and Lallier, 1988) . Cranial neural crest is actively
migrating at stage 10, and GalTase immunoreactivity is de-
tectable on these cells . Furthermore, GalTase is found on ac-
tively migrating head mesenchymal cells, however mesen-
chymal cell migration is not affected by blocking surface
GalTase activity. Collectively, these results further suggest
a functional redundancy, or overlap, of cell surface receptors
during later stages of cranial neural crest cell migration and
during mesenchymal cell migration . A similar phenomenon
has been proposed in Drosophila nervous system develop-
ment . Fasciclin I, a membrane-associated glycoprotein ex-
pressed on many neural cell types, mediates cell-cell adhe-
sion in transfected cells, yet the complete loss of the gene
product in vivo results in a normal nervous system pheno-
type, suggesting that other adhesion molecules participate in
the same developmental processes (Elkins et al ., 1990) . It
is equally likely that neural crest cell migration in stage 10
or older embryos may rely on as yet undefined cell-matrix
or cell-cell receptors .
In addition to perturbing neural crest cell migration, anti-
GalTase Fab treatment had a significant effect on neural tube
formation . In 61% of the embryos examined, neural tubes ei-
ther failed to close or closed abnormally, resulting in a dor-
sally bifurcated neural tube. Martins-Green (1988) and
Schoenwolf and Smith (1990) have described three critical
and independent events during cranial neural tube formation
in chick embryos : (1) median hinge formation resulting from
interactions between the neural plate and notochord, (2) ele-
vation of the neural folds, and (3) lateral hinge formation
resulting in the apposition of the dorsal neural folds (Smith
and Schoenwolf, 1989 ; Placzek et al., 1990) . The simplest
explanation for the effects of anti-GalTase Fab on neural tube
development is that cell surface GalTase is required for neu-
ral fold elevation, lateral hinge formation, or both, sinceme-
dian hinges formed normally in this study. (It is possible that
anti-GalTase Fab was injected after the sensitive period) .
Neural fold elevation was inhibited in the youngest embryos
treated with anti-GalTase Fab, whereas lateral hinge forma-
tion was affected in the majority of Fab-injected embryos
showing neural tube defects . The dorsolateral hinges form at
the point where ectoderm and neural folds are in contact
(Martins-Green, 1988 ; Schoenwolf and- Smith, 1990), an
area rich in several extracellular matrix molecules (Tucker
et al ., 1988), particularly laminin (Martins-Green and
Erickson, 1987), and GalTase immunoreactivity. Therefore,
it is possible that cell surface GalTase may participate in neu-
ral tube formation by interacting with laminin in the basal
lamina .
Neural tube defects were seen only with Fab treatment but
not with IgG treatment, an observation for which there are
several possible explantations . Anti-GalTase Fab was amore
potent inhibitor of neural crest cell migration on laminin in
pilot in vitro studies ; therefore, itmay have been a more po-
tent inhibitor of cell surface GalTase function in vivo . Alter-
natively, there is evidence to suggest that neural tube forma-
tion can occur normally if one side of the neural tube is
mechanically separated at the presumptive neural epithe-
lial/ectodermal interface ; neurulation is completely in-
hibited only if both sides are perturbed (Schoenwolf and
Smith, 1990) . Because IgG did not cross the midline, this
reagent may have been prevented from producing neural tube
defects .
In summary, cell surface GalTase appears to participate in
cranial neural crest cell migration, perhaps by interacting
with laminin in the embryonic basal lamina, in the extracel-
lular space, or both . In addition, cell surface GalTase plays
an as yet undefined role in early neural tube formation . It is
unlikely that defects in neural crest cell migration are a sec-
ondary result of defective neurulation, since neural crest cell
defects were often found in embryos with normal neurula-
tion, particularly with IgG-treated embryos . One possibility
is that surface GalTase on neural epithelia interacts with
laminin within the basal lamina of the neural tube and that
this interaction is critical for proper neural tube closure.
Studies are currently under way to determine the distribution
of GalTase at the ultrastructural level, and to address in de-
tail the role of cell surface GalTase during neural develop-
ment using in vitro whole embryo culture systems .
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Figure 12 . Immunofluorescence localization ofGalTase on sectioned embryos . (a) Before theonset of migration, neural crest cells associated
with thedorsal neural tube (*) did not label for GalTase . (c) However, GalTase was expressed as migrationbegan, particularly atthe leading
edge of the cluster of migrating neural crest cells (arrow) . (d) At later stages of neural crest cell migration, neural crest cells retained high
levels of GalTase expression (arrows) . (e) Anti-GalTase immunoreactivity on the basal surfaces of neural epithelial cells was best seen in
younger (stage 8-) embryos with a preembedding immunofluorescence technique described in Materials and Methods . The basal surface
ofneural epithelial cells was heavily labeled for GalTase (arrowheads) during neural tube closure . (g) GalTase reactivity was also localized
tothe interface betweentheneuralepithelialbasal surface and theoverlying ectoderm as the neural folds become apposed (large arrowheads) .
(h) GalTase was localized to basal surfaces ofseveral cell types in older (stage 11+) embryos, including the basal neural epithelium, the no-
tochord (arrowhead), the gut endoderm (smallarrows), and the vascular endothelium (small arrowheads) . Actively migrating head mesen-
chymal cells (a, c, and d, large arrowheads) also labeled for GalTase, as did the apical surfaces and regions of ectodermal cells (c, d, and
g, small arrowheads), which are presumably secreting Golgi-derived GalTase . (b andf) Control sections were incubated with preitnmune
sera and demonstrate nonspecific background levels of immunoreactivity . a-d, g, and h were embedded in low-temperature medium and
reacted withantibodies after sectioning, and e andfwere reacted withantibodies prior to embedding, all as described in Materials and Meth-
ods . Bars : 50 pm (a and b) ; 25 pm (c-h) .
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